Equities

Celadon Pharmaceuticals PLC

CEL:LSE

Celadon Pharmaceuticals PLC

Health CarePharmaceuticals and Biotechnology
  • Price (GBX)101.50
  • Today's Change0.00 / 0.00%
  • Shares traded4.32k
  • 1 Year change-28.77%
  • Beta-0.0696
Data delayed at least 20 minutes, as of May 09 2024 17:08 BST.
More ▼

IC View

The last IC recommendation on Celadon Pharmaceuticals PLC shares was Hold at 164.00 on 05 Jun 2023Read the full article

Key statistics

On Thursday, Celadon Pharmaceuticals PLC (CEL:LSE) closed at 101.50, 38.21% above the 52 week low of 73.44 set on Nov 14, 2023.
52-week range
Today
73.44Nov 14 2023180.00May 31 2023
Open101.50
High100.00
Low100.00
Bid90.00
Offer105.00
Previous close101.50
Average volume19.80k
Shares outstanding64.21m
Free float21.74m
P/E (TTM)--
Market cap65.17m GBP
EPS (TTM)-0.1306 GBP
Data delayed at least 20 minutes, as of May 09 2024 17:08 BST.
More ▼
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.